Royalty Pharma Plc (RPRX)
45.19
+0.39
(+0.87%)
USD |
NASDAQ |
Feb 13, 16:00
45.20
+0.01
(+0.02%)
After-Hours: 20:00
Royalty Pharma Shareholders Equity (Quarterly) : 6.477B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Denali Therapeutics, Inc. | 926.20M |
| PTC Therapeutics, Inc. | -155.76M |
| Veru, Inc. | 37.12M |
| Incyte Corp. | 5.167B |
| Vertex Pharmaceuticals, Inc. | 18.67B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.62B |
| Total Liabilities (Quarterly) | 9.906B |
| Debt to Equity Ratio | 1.384 |
| Current Ratio | 2.402 |
| Net Debt Paydown Yield | -1.64% |